Navigation Links
Five AIDS Patients To Receive Experimental Anti-retroviral Drugs

A group of five AIDS victims who have been trying to gain special access to the much sought unapproved anti- HIV drugs (TMC 114 and TMC 125) can now rejoice as the Health Canada // has now issued the medication in what can be considered as a rare clinical trial.

Dr. Montaner, an AIDS drugs specialist with the B.C. Centre for Excellence in HIV/AIDS at St. Paul's Hospital has been trying hard to bring the two unapproved drugs into Canada as a special case. He had even submitted an application to Health Canada in this regard. A special access program that is designed to get unapproved drugs to terminally ill patients was his only hope.

"We started nine months ago looking for treatment. In that time, unfortunately, one [of the six men] has died. We need to make sure we do the best for the patients at all times and not get hung up on unnecessary bureaucratic delays," said Montaner.

Health Canada however refused the request on grounds of inadequate data regarding the synergistic effect of the two drugs. Following this, the doctor and his team sought the help of media and politicians. Unable to withstand the pressure, it has been decided to provide the patients with the drug under a unique approach, a clinical trial.

The chair of St. Paul's ethical-review board that approved the protocol has requested for minor changes to be incorporated in the patient consent forms. The clinical trail is believed to ensure better monitoring of the five patients. A contract would soon by signed between the hospital and the drug supplier, Tibotec Inc., which has agreed to provide the drug free of cost.

The drug is hoped to reach the patients in the coming year. One of the proposed recipient, B.C. artist Tiko Kerr has expressed his feelings of joy following the announcement. He his nervous system has already been affected. Infact he has already lost sensation in his feet and one hand. He manages to do painting with the other hand in which th ere is some sensation preserved.

Health Minister Ujjal Dosanjh has also been very active in ensuring drug supply to the victims. He met another patient, Paul Lewand, chairman of the B.C. Persons with AIDS Society. While the whole world visualises a hopeless end for AIDS victims, this move is expected to infuse an endless hope amongst the five victims.
'"/>




Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... As part ... two webinars in February 2016. Each webinar features a dynamic expert and thoughtful ... benefit their athletes, patients and facilities. Both events are free to attend, but ...
(Date:2/10/2016)... ... February 10, 2016 , ... Emergency rooms provide emergency care to ... this can leave patients with dental emergencies at risk of losing a tooth or ... dental care. , Common dental emergencies include:, , Avulsed ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... bring together more than 200 of the country’s top healthcare executives to share ... “The true benefit of the Forum is the provider-centric perspective, experience, expertise and ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The ... and inspirational speaker Jan Fox will serve as keynote speaker at the organization’s ... participants with tools to more effectively communicate with their own organizational staff and ...
(Date:2/10/2016)... ... 10, 2016 , ... Everseat has joined the award-winning Allscripts ... physicians. The integration will enable Allscripts users to post open appointments to the ... app. , The partnership gives Everseat substantial added power to help Allscripts meet ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... Feb. 9, 2016  Until recently, the options for ... liposuction. Thankfully, the FDA approved the non-invasive Coolsculpting treatment, ... Coolsculpting was originally approved in 2010 for the abdomen ... now the chin. With this add-on approval, the experts ... a smaller applicator, the CoolMini, to address smaller areas ...
(Date:2/10/2016)... India , February 10, 2016 ... The "Personalized Medicine, Targeted Therapeutics and Companion Diagnostic ... Trends, Technologies, Participants, and Environment" research report indicates ... worth over $149 billion by 2020 growing at ... up of companion diagnostics and targeted therapeutics and ...
(Date:2/9/2016)... , Feb. 9, 2016 /PRNewswire/ - Nevro Corp. ... that is providing innovative evidence-based solutions for the treatment ... financial results for the fourth quarter and full year ... 2016. Company management will host a conference call beginning ... on Monday, February 29, 2016. www.nevro.com . ...
Breaking Medicine Technology: